Global expansion Boerhinger Ingelheim is expanding its U.S. footprint with a new Animal Health headquarters in Johns Creek, Georgia, signaling increased demand for veterinary solutions and cross-border supply chain capabilities that sales teams can capitalize on with integrated product offerings and regional partnerships.

Scale manufacturing Significant investment in the Xochimilco plant to reach 5 billion tablets annually positions BI as a major supplier for global markets, presenting opportunities to upsell manufacturing services, contract development, and large-volume contract manufacturing partnerships.

Portfolio highlights Recent validation through Phase IIa/IIb results for BI 1839100 in chronic cough IPF signals ongoing R&D progress and potential launches, suggesting sales avenues in clinical data support, regulatory strategy collaboration, and early access programs.

Digital and data enablement A tech stack including integrated engagement platforms and analytics tools indicates readiness for digital health solutions, offering opportunities to tailor digital patient engagement, remote monitoring, and data-driven commercialization services for both human and animal health segments.

Access to care momentum Historical Access to Healthcare initiatives in markets like Kenya demonstrate a commitment to patient-centric programs, creating potential for partnerships on affordable care, supply chain resilience, and value-based selling in emerging markets and underserved populations.